Microtubule Dynamics, Mitotic Arrest, and Apoptosis: Drug-Induced Differential Effects of βIII-Tubulin

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-09-0679PMID 20442307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microtubules and resistance to tubulin-binding agents

  2010cited by this paper
• Microtubules and resistance to tubulin-binding agents

  2010cited by this paper
• Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?

  2008cited by this paper
• Class III β-Tubulin Mediates Sensitivity to Chemotherapeutic Drugs in Non–Small Cell Lung Cancer

  2007cited by this paper
• Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.

  2007cited by this paper
• How do microtubule-targeted drugs work? An overview.

  2007cited by this paper
• βIII-Tubulin Induces Paclitaxel Resistance in Association with Reduced Effects on Microtubule Dynamic Instability*

  2005cited by this paper
• Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest.

  2004cited by this paper
• Microtubules as a target for anticancer drugs

  2004cited by this paper
• Suppression of centromere dynamics by Taxol in living osteosarcoma cells.

  2003cited by this paper
• Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation.

  2003cited by this paper
• Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.

  2003cited by this paper
• The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics.

  2003cited by this paper
• Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics

  2001cited by this paper
• Taxol suppresses dynamics of individual microtubules in living human tumor cells.

  1999cited by this paper
• Dual cytotoxic mechanisms of submicromolar taxol on human leukemia HL-60 cells.

  1997cited by this paper
• Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.

  1997cited by this paper
• Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death.

  1996cited by this paper
• Vinblastine suppresses dynamics of individual microtubules in living interphase cells.

  1995cited by this paper
• Microtubule dynamics in vitro are regulated by the tubulin isotype composition.

  1994influential reference
• Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of beta-tubulin.

  1990cited by this paper
• Dynamic instability of microtubule growth

  1984cited by this paper

• TUBB3 (βIII-tubulin) drives gastric cancer progression and poor prognosis by regulating cell cycle and invadopodia formation

  2025cites this paper
• The emerging tools for precisely manipulating microtubules.

  2024cites this paper
• Regulation of microtubule growth rates and their impact on chromosomal instability

  2024cites this paper
• A modified natural small molecule inhibits triple-negative breast cancer growth by interacting with Tubb3.

  2023cites this paper
• Antineoplastic effect of paclitaxel-loaded polymeric nanocapsules on malignant human ovarian carcinoma cells (SKOV-3)

  2023cites this paper
• The phosphatase of regenerating liver-3 protein (PRL-3) promotes glioma cell invasiveness by interacting with β3 –tubulin

  2022cites this paper
• Transcriptome analysis of microRNAs, circRNAs, and mRNAs in the dorsal root ganglia of paclitaxel-induced mice with neuropathic pain

  2022cites this paper
• βIII-Tubulin Gene Regulation in Health and Disease

  2022cites this paper
• SRC Kinase-Mediated Tyrosine Phosphorylation of TUBB3 Regulates Its Stability and Mitotic Spindle Dynamics in Prostate Cancer Cells

  2022cites this paper
• Carboplatin Plus Vincristine as an Alternative Chemotherapeutic Scheme in Patients With Glioblastoma

  2022cites this paper
• βIII-Tubulin Structural Domains Regulate Mitochondrial Network Architecture in an Isotype-Specific Manner

  2022cites this paper
• Improving therapeutic synergy score predictions with adverse effects using multi-task heterogeneous network learning

  2022cites this paper
• βIII‐tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c‐Met positive non‐small cell lung cancer cells

  2022cites this paper
• βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies.

  2021cites this paper
• Clinical and biochemical markers in CIPN: A reappraisal.

  2021cites this paper
• Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles

  2021cites this paper
• Personalized Medicine for Neuroblastoma: Moving from Static Genotypes to Dynamic Simulations of Drug Response

  2021cites this paper
• Drug-Induced Peripheral Neuropathy: Diagnosis and Management.

  2021cites this paper
• Disassembly of microtubules by intense terahertz pulses.

  2021cites this paper
• Discovery of a Series of Hydroxamic Acid-Based Microtubule Destabilizing Agents with Potent Antitumor Activity.

  2021cites this paper
• Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy

  2021cites this paper
• Expression of ATP/GTP Binding Protein 1 Has Prognostic Value for the Clinical Outcomes in Non-Small Cell Lung Carcinoma

  2020cites this paper
• The Tubulin Code in Microtubule Dynamics and Information Encoding.

  2020cites this paper
• Development of a LC-MS/MS Method for a New Ortho-aryl Chalcone Compound of OC26 and its Application to Bile

  2020cites this paper
• Exogenous Expression of WNT7A in Leukemia-Derived Cell Lines Induces Resistance to Chemotherapeutic Agents.

  2020cites this paper
• Molecular mechanisms of synergistic action of Ramucirumab and Paclitaxel in Gastric Cancers cell lines

  2020cites this paper
• Beta3-Tubulin Is Critical for Microtubule Dynamics, Cell Cycle Regulation, and Spontaneous Release of Microvesicles in Human Malignant Melanoma Cells (A375)

  2020cites this paper
• A Survey on Tubulin and Arginine Methyltransferase Families Sheds Light on P. lividus Embryo as Model System for Antiproliferative Drug Development

  2019cites this paper
• Valproic acid promotes mature neuronal differentiation of adipose tissue-derived stem cells through iNOS-NO-cGMP signaling pathway.

  2019cites this paper
• Assessing the utility of in vitro microtubule assays for studying mechanisms of peripheral neuropathy with the microtubule inhibitor class of cancer chemotherapy.

  2019cites this paper
• Resistance to anti-tubulin agents: From vinca alkaloids to epothilones

  2019cites this paper
• Inflammatory and neuropathic gene expression signatures of chemotherapy-induced neuropathy induced by vincristine, cisplatin and oxaliplatin in C57BL/6J mice.

  2019cites this paper
• Benzothienoquinazolinones as new multi-target scaffolds: Dual inhibition of human Topoisomerase I and tubulin polymerization.

  2019cites this paper
• Cellular Heterogeneity

  2018cites this paper
• Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway

  2018cites this paper
• β-Tubulin carboxy-terminal tails exhibit isotype-specific effects on microtubule dynamics in human gene-edited cells

  2018cites this paper
• Minimizing Risk of Cancer Therapeutics.

  2018cites this paper
• Zerumbone, a cyclic sesquiterpene, exerts antimitotic activity in HeLa cells through tubulin binding and exhibits synergistic activity with vinblastine and paclitaxel

  2018cites this paper
• Novel 1,2,4-triazole derivatives as potential anticancer agents: Design, synthesis, molecular docking and mechanistic studies.

  2018cites this paper
• Analysis of Microtubule Dynamics Heterogeneity in Cell Culture.

  2018cites this paper
• Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent.

  2017cites this paper
• Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules

  2017cites this paper
• Mechanisms of kinetic stabilization by the drugs paclitaxel and vinblastine

  2017cites this paper
• Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy

  2017cites this paper
• Vincristine alleviates adriamycin-induced nephropathy through stabilizing actin cytoskeleton

  2017influential citation
• βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel

  2017cites this paper
• New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer.

  2017cites this paper
• Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways

  2017cites this paper
• An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance

  2017cites this paper
• Targeting PAM signaling pathway in the treatment of pancreatic ductal adenocarcinoma

  2017cites this paper
• Modification of C-seco taxoids through ring tethering and substituent replacement leading to effective agents against tumor drug resistance mediated by βIII-Tubulin and P-glycoprotein (P-gp) overexpressions.

  2017cites this paper
• Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids12

  2016cites this paper
• Phosphorylation of αB-crystallin: Role in stress, aging and patho-physiological conditions.

  2016cites this paper
• βIII-Tubulin alters glucose metabolism and stress response signaling to promote cell survival and proliferation in glucose-starved non-small cell lung cancer cells.

  2016cites this paper
• Removal of the mechanoprotective influence of the cytoskeleton reveals PIEZO1 is gated by bilayer tension

  2016cites this paper
• Tubb3 regulation by the Erk and Akt signaling pathways: a mechanism involved in the effect of arginine ADP-ribosyltransferase 1 (Art1) on apoptosis of colon carcinoma CT26 cells

  2016cites this paper
• Classical Hodgkin lymphoma primary refractory to brentuximab vedotin, with transformation to CD30-positive diffuse large B-cell lymphoma

  2016cites this paper
• Current Advances of Tubulin Inhibitors in Nanoparticle Drug Delivery and Vascular Disruption/Angiogenesis

  2016cites this paper
• Effect of CH-35, a novel anti-tumor colchicine analogue, on breast cancer cells overexpressing the βIII isotype of tubulin

  2016cites this paper
• CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo

  2016cites this paper
• The synthetic diazonamide DZ-2384 has distinct effects on microtubule curvature and dynamics without neurotoxicity

  2016cites this paper
• Implicación de los polimorfismos genéticos en la neurotoxicidad por Vincristina en pacientes pediátricos diagnosticados de Leucemia Linfoblástica Aguda

  2016cites this paper
• Regulation of microtubule (MT)-based cytoskeleton in the seminiferous epithelium during spermatogenesis.

  2016cites this paper
• Promising SINEs in the Treatment of Pancreatic Cancer

  2015cites this paper
• Medicinal Plants: A Potential Source of Compounds for Targeting Cell Division

  2015cites this paper
• TUBB 3 / b III-Tubulin Acts through the PTEN / AKT Signaling Axis to Promote Tumorigenesis and Anoikis Resistance in Non – Small Cell Lung Cancer

  2015cites this paper
• Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling.

  2015cites this paper
• Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins

  2015cites this paper
• Medicinal Plants: A Potential Source of Compounds for Targeting Cell Division

  2015cites this paper
• Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?

  2015cites this paper
• Use of TUBB3 for patient stratification and prognosis in lung cancer

  2015cites this paper
• TUBB3/βIII-tubulin acts through the PTEN/AKT signaling axis to promote tumorigenesis and anoikis resistance in non-small cell lung cancer.

  2015cites this paper
• Emerging microtubule targets in glioma therapy.

  2015cites this paper
• Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulin

  2014cites this paper
• Targeting Pericytes for Angiogenic Therapies

  2014cites this paper
• Pericyte Dynamics during Angiogenesis: New Insights from New Identities

  2014cites this paper
• Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.

  2014cites this paper
• Sequential targeted delivery of paclitaxel and camptothecin using a cross-linked "nanosponge" network for lung cancer chemotherapy.

  2014cites this paper
• Putative role for the GTPase, hGBP-1, in tumor cell proliferation and resistance to paclitaxel

  2014cites this paper
• Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy

  2014cites this paper
• Microtubules and Their Role in Cellular Stress in Cancer

  2014cites this paper
• βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer

  2014cites this paper
• Partial Depletion of Gamma-Actin Suppresses Microtubule Dynamics

  2013influential citation
• Interference of a novel indolylmaleimide with microtubules induces mitotic arrest and apoptosis in human progenitor and cancer cells.

  2013cites this paper
• Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers.

  2013cites this paper
• Structure-activity relationship and in vitro and in vivo evaluation of the potent cytotoxic anti-microtubule agent N-(4-methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-aminium chloride and its analogues as antitumor agents.

  2013cites this paper
• Cytoskeletal alterations that confer resistance to anti-tubulin chemotherapeutics.

  2012cites this paper
• Cytoskeleton and Human Disease

  2012cites this paper
• Distinct Functional Roles of β-Tubulin Isotypes in Microtubule Arrays of Tetrahymena thermophila, a Model Single-Celled Organism

  2012cites this paper
• A novel sulfonamide agent, MPSP-001, exhibits potent activity against human cancer cells in vitro through disruption of microtubule

  2012cites this paper
• Preclinical Development b II-Tubulin and b III-Tubulin Mediate Sensitivity to Peloruside A and Laulimalide , but not Paclitaxel or Vinblastine , in Human Ovarian Carcinoma Cells

  2012cites this paper
• Tubulins as therapeutic targets in cancer: from bench to bedside.

  2012cites this paper
• Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failure

  2012cites this paper
• Discovery of Novel 2‐N‐Aryl‐Substituted Benzenesulfonamidoacetamides: Orally Bioavailable Tubulin Polymerization Inhibitors with Marked Antitumor Activities

  2012cites this paper
• Novel drugs targeting microtubules: the role of epothilones.

  2012cites this paper
• Microtubules, Drug Resistance, and Tumorigenesis

  2012cites this paper
• Molecular crosstalk between apoptosis and autophagy induced by a 2-methoxyestradiol analogue (C19) in HeLa cells

  2012cites this paper
• Identification of class III β-tubulin as a marker of angiogenic perivascular cells.

  2012cites this paper
• Src family kinases and paclitaxel sensitivity

  2011cites this paper
• Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics.

  2011cites this paper